Trends in Prostate-Specific Antigen Screening Since the Implementation of the 2012 US Preventive Services Task Force Recommendations

Eur Urol Focus. 2018 Dec;4(6):1002-1004. doi: 10.1016/j.euf.2017.02.004. Epub 2017 Feb 22.

Abstract

In 2012, the US Preventive Services Task Force recommended against prostate-specific antigen (PSA) screening. Following the initial decrease in PSA screening rate, there appears to be no further decrease in screening rate from 2013 to 2015. In addition, the screening rate did not differ by age or race.

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Advisory Committees
  • Aged
  • Asian
  • Black or African American
  • Early Detection of Cancer / standards
  • Early Detection of Cancer / trends*
  • Ethnicity*
  • Hispanic or Latino
  • Humans
  • Kallikreins / blood*
  • Logistic Models
  • Male
  • Middle Aged
  • Multivariate Analysis
  • Practice Guidelines as Topic*
  • Preventive Health Services
  • Prostate-Specific Antigen / blood*
  • Prostatic Neoplasms / blood
  • Prostatic Neoplasms / diagnosis*
  • United States
  • White People

Substances

  • KLK3 protein, human
  • Kallikreins
  • Prostate-Specific Antigen